Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner
Authors
Keywords
Childhood leukemia, Mass spectrometry, Proteomics, Two-dimensional gel electrophoresis
Journal
Journal of Hematology & Oncology
Volume 6, Issue 1, Pages 52
Publisher
Springer Nature
Online
2013-07-12
DOI
10.1186/1756-8722-6-52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Network views for personalized medicine
- (2013) Antonia Vlahou Proteomics Clinical Applications
- Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer
- (2012) Z. Niu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC–MS/MS Data Sets
- (2012) Eric J. Foss et al. JOURNAL OF PROTEOME RESEARCH
- Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: Multiple, diverse signals converging on a few key downstream regulators
- (2012) George I. Lambrou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome
- (2011) William CS Cho Expert Review of Proteomics
- Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL)
- (2011) Nan Jiang et al. Journal of Proteomics
- Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
- (2011) M. Shiota et al. MOLECULAR CANCER RESEARCH
- Insights on neoplastic stem cells from gel-based proteomics of childhood germ cell tumors
- (2011) William E. Haskins et al. PEDIATRIC BLOOD & CANCER
- A lipoprotein source of cholesteryl esters is essential for proliferation of CEM-CCRF lymphoblastic cell line
- (2011) Sabrina Uda et al. TUMOR BIOLOGY
- Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses
- (2010) Maria Braoudaki et al. AMINO ACIDS
- High Prevalence of Low Vitamin D and Musculoskeletal Complaints in Women with Breast Cancer
- (2010) Nicola Napoli et al. Breast Journal
- Plasma testosterone and sex hormone-binding globulin concentrations and the risk of prostate cancer among Japanese men: A nested case-control study
- (2010) Norie Sawada et al. CANCER SCIENCE
- Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis
- (2010) John D. Andersen et al. ELECTROPHORESIS
- The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
- (2010) P. Saunders et al. HAEMATOLOGICA
- A Novel Protease-activated Receptor-1 Interactor, Bicaudal D1, Regulates G Protein Signaling and Internalization
- (2010) Steven Swift et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The frequency of NPM1 mutations in childhood acute myeloid leukemia
- (2010) Maria Braoudaki et al. Journal of Hematology & Oncology
- Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a pediatric hematology/oncology unit
- (2010) Katerina Katsibardi et al. LEUKEMIA & LYMPHOMA
- Proteomic profile of a therapy related acute myeloid leukemia following brain tumor
- (2010) Maria Braoudaki et al. LEUKEMIA & LYMPHOMA
- Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma
- (2010) Bogusz Trojanowicz et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL
- (2010) Benedetta Accordi et al. PLoS One
- Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin
- (2010) Siti S Abdullah-Soheimi et al. Proteome Science
- Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia
- (2009) R. M. A. Linger et al. BLOOD
- Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian Cancer
- (2009) H. Dieplinger et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer
- (2009) Li Wei et al. INTERNATIONAL JOURNAL OF CANCER
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: Usefulness of gelsolin protein
- (2009) Mihoko Ohnishi et al. PATHOLOGY INTERNATIONAL
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis
- (2008) Alexander Hamm et al. BMC CANCER
- 2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer
- (2008) Jennifer C. Byrne et al. JOURNAL OF PROTEOME RESEARCH
- Mass spectrometry-based proteomics in reproductive medicine
- (2008) Aggeliki Kolialexi et al. MASS SPECTROMETRY REVIEWS
- STRING 8--a global view on proteins and their functional interactions in 630 organisms
- (2008) L. J. Jensen et al. NUCLEIC ACIDS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started